1-4 of 4
Keywords: APOE
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Neurodegener Dis (2019) 19 (3-4): 139–147.
Published Online: 17 December 2019
...Sven Haller; Marie-Louise Montandon; Cristelle Rodriguez; Valentina Garibotto; François R. Herrmann; Panteleimon Giannakopoulos Background: Hippocampal volume loss (HVL), PET-documented brain amyloid accumulation, and APOE-ε4 status are predictive biomarkers of the transition from mild cognitive...
Journal Articles
Journal Articles
Neurodegener Dis (2011) 8 (5): 289–295.
Published Online: 11 February 2011
... study. A clinical evaluation and a standardized assessment were carried out. Each patient underwent blood sampling for genetic testing, and mutations within the progranulin (PGRN) gene, microtubule-associated protein tau (MAPT) haplotype, apolipoprotein E (APOE) genotype and 4 vascular endothelial...
Journal Articles
Neurodegener Dis (2008) 5 (3-4): 176–178.
Published Online: 06 March 2008
... response in AD is genotype specific, with APOE-4/4 carriers as the worst responders to conventional treatments. In addition, about 10–20% of Caucasians are carriers of defective CYP2D6 polymorphic variants that alter the metabolism and effects of AD drugs and many psychotropic agents currently administered...